Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-02 · accession 0001209191-21-054825 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-03 | 2021-09-02 | TCRT | Postma Robert W | Dir | P - Purchase | $1.73 | +20.5K | 1.20M | +2% | +$35.5K | |
| I | 2021-09-03 | 2021-09-02 | TCRT | Postma Robert W | Dir | P - Purchase | $1.73 | +54.5K | 4.25M | +1% | +$94.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-02 | P | A | 20,508 | $1.73 | 1,201,870 | D See footnote | — | — | (F1) Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the "Units") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock. (F2) The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill. |
| 2 | Common | Common Stock | 2021-09-02 | P | A | 54,492 | $1.73 | 4,250,000 | I | — | — |